SEC Filing Details
Document Details
Form
Filing Date
Nov 2, 2026
Document Date
Nov 2, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
SAKHAMURI SIVAKESAVA